chr3-64540936-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_182920.2(ADAMTS9):c.5521+159A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0626 in 152,222 control chromosomes in the GnomAD database, including 909 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.063 ( 909 hom., cov: 34)
Consequence
ADAMTS9
NM_182920.2 intron
NM_182920.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.132
Genes affected
ADAMTS9 (HGNC:13202): (ADAM metallopeptidase with thrombospondin type 1 motif 9) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. Members of the ADAMTS family have been implicated in the cleavage of proteoglycans, the control of organ shape during development, and the inhibition of angiogenesis. This gene is localized to chromosome 3p14.3-p14.2, an area known to be lost in hereditary renal tumors. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 3-64540936-T-C is Benign according to our data. Variant chr3-64540936-T-C is described in ClinVar as [Benign]. Clinvar id is 1251849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.252 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS9 | NM_182920.2 | c.5521+159A>G | intron_variant | ENST00000498707.5 | NP_891550.1 | |||
ADAMTS9 | NM_001318781.2 | c.5437+159A>G | intron_variant | NP_001305710.1 | ||||
ADAMTS9 | XR_007095711.1 | n.5780+159A>G | intron_variant, non_coding_transcript_variant | |||||
ADAMTS9 | XR_245151.1 | n.5864+159A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS9 | ENST00000498707.5 | c.5521+159A>G | intron_variant | 1 | NM_182920.2 | ENSP00000418735 | P1 | |||
ADAMTS9 | ENST00000295903.8 | c.5437+159A>G | intron_variant | 1 | ENSP00000295903 | |||||
ADAMTS9 | ENST00000481060.2 | c.2688+159A>G | intron_variant | 2 | ENSP00000417521 |
Frequencies
GnomAD3 genomes AF: 0.0625 AC: 9514AN: 152104Hom.: 902 Cov.: 34
GnomAD3 genomes
AF:
AC:
9514
AN:
152104
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0626 AC: 9533AN: 152222Hom.: 909 Cov.: 34 AF XY: 0.0662 AC XY: 4928AN XY: 74430
GnomAD4 genome
AF:
AC:
9533
AN:
152222
Hom.:
Cov.:
34
AF XY:
AC XY:
4928
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
354
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at